Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Psychopharmacologic treatment of children and adolescents with anxiety disorders.

Publication ,  Journal Article
Strawn, JR; Sakolsky, DJ; Rynn, MA
Published in: Child Adolesc Psychiatr Clin N Am
July 2012

Over the last decade, psychopharmacologic treatments for pediatric anxiety disorders have been developed and increasingly subjected to randomized, controlled trials. The authors summarize the data concerning the use of tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), atypical anxiolytics, and benzodiazepines. The extant data suggest that SSRIs--both as monotherapy and when combined with psychotherapy--are effective in the treatment of pediatric anxiety disorders. In addition, some TCAs and SNRIs are effective. However, randomized controlled trials do not suggest efficacy for benzodiazepines or the atypical anxiolytic, buspirone, for children and adolescents with anxiety disorders.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Child Adolesc Psychiatr Clin N Am

DOI

EISSN

1558-0490

Publication Date

July 2012

Volume

21

Issue

3

Start / End Page

527 / 539

Location

United States

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Randomized Controlled Trials as Topic
  • Practice Guidelines as Topic
  • Male
  • Humans
  • Female
  • Developmental & Child Psychology
  • Combined Modality Therapy
  • Cognitive Behavioral Therapy
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Strawn, J. R., Sakolsky, D. J., & Rynn, M. A. (2012). Psychopharmacologic treatment of children and adolescents with anxiety disorders. Child Adolesc Psychiatr Clin N Am, 21(3), 527–539. https://doi.org/10.1016/j.chc.2012.05.003
Strawn, Jeffrey R., Dara J. Sakolsky, and Moira A. Rynn. “Psychopharmacologic treatment of children and adolescents with anxiety disorders.Child Adolesc Psychiatr Clin N Am 21, no. 3 (July 2012): 527–39. https://doi.org/10.1016/j.chc.2012.05.003.
Strawn JR, Sakolsky DJ, Rynn MA. Psychopharmacologic treatment of children and adolescents with anxiety disorders. Child Adolesc Psychiatr Clin N Am. 2012 Jul;21(3):527–39.
Strawn, Jeffrey R., et al. “Psychopharmacologic treatment of children and adolescents with anxiety disorders.Child Adolesc Psychiatr Clin N Am, vol. 21, no. 3, July 2012, pp. 527–39. Pubmed, doi:10.1016/j.chc.2012.05.003.
Strawn JR, Sakolsky DJ, Rynn MA. Psychopharmacologic treatment of children and adolescents with anxiety disorders. Child Adolesc Psychiatr Clin N Am. 2012 Jul;21(3):527–539.
Journal cover image

Published In

Child Adolesc Psychiatr Clin N Am

DOI

EISSN

1558-0490

Publication Date

July 2012

Volume

21

Issue

3

Start / End Page

527 / 539

Location

United States

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Randomized Controlled Trials as Topic
  • Practice Guidelines as Topic
  • Male
  • Humans
  • Female
  • Developmental & Child Psychology
  • Combined Modality Therapy
  • Cognitive Behavioral Therapy
  • Child